{
  "query": "symptoms adverse withdrawal continuous",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT04822909",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Erythema Nodosum Leprosum"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02989857",
          "briefTitle": "Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cholangiocarcinoma", "Metastatic Cholangiocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 187,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00823719",
          "briefTitle": "Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Large-Cell, Diffuse"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01563029",
          "briefTitle": "A Dose-ranging Study of Fluticasone Furoate (FF)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-09-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 597,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "11 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04415853",
          "briefTitle": "Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Esophageal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 416,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00001575",
          "briefTitle": "Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1997-04"
          },
          "completionDateStruct": {
            "date": "2013-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hodgkin's Disease", "Lymphoma, Non-Hodgkin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 87,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00949702",
          "briefTitle": "A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-06-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 132,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03959280",
          "briefTitle": "CPAP, Nutrition & Exercise Against Sleep Apnea"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sleep Apnea", "Overweight and Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01672970",
          "briefTitle": "A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2015-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 291,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07015996",
          "briefTitle": "Efficacy of Tezepelumab in Peanut Oral Immunotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-18",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-09-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Peanut Allergy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03441360",
          "briefTitle": "Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed/Refractory Rhabdomyosarcoma", "Non-rhabdomyosarcoma Soft Tissue Sarcoma", "Ewing Sarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03227224",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Depressive Disorder, Major"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 287,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02510014",
          "briefTitle": "Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Opioid Use Disorder", "Opioid-related Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 775,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02634281",
          "briefTitle": "Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking Cessation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 242,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03054064",
          "briefTitle": "Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cerebrovascular Accident (CVA)", "Stroke", "Hemiplegia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02725411",
          "briefTitle": "Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Low Back Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 277,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01649557",
          "briefTitle": "Multicenter, Open-label, Safety and Tolerability Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Schizophrenia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 244,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "67 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03297970",
          "briefTitle": "Bogota School Children Cohort"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Nutrition", "Child Health", "Child Growth", "Neurocognitive Development", "Sexual Maturation", "Infectious Morbidity", "Behavior Problem"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3202,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01943851",
          "briefTitle": "A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 111,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02083354",
          "briefTitle": "Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Melanoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 77,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01122927",
          "briefTitle": "Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07"
          },
          "completionDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adolescent Schizophrenia", "Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 524,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02227238",
          "briefTitle": "Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 627,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04708106",
          "briefTitle": "Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Electronic Cigarette Use"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 194,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "22 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07041827",
          "briefTitle": "Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non Hodgkin Lymphoma", "DLBCL", "Cardiovascular Diseases", "Cardiomyopathies", "Cardiotoxicity", "Metabolic Syndrome", "Quality of Life", "Late Effect", "Heart Failure"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 217,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06006546",
          "briefTitle": "The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic HIV Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06426160",
          "briefTitle": "Tocilizumab for Painful Chronic Pancreatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pancreatitis, Chronic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02763579",
          "briefTitle": "A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Small Cell Lung Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 503,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02330991",
          "briefTitle": "A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glioblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06199089",
          "briefTitle": "A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Immune Thrombocytopenia", "Treatment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03809897",
          "briefTitle": "Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Tobacco Use Cessation", "Psychiatric Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00950755",
          "briefTitle": "Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-06"
          },
          "completionDateStruct": {
            "date": "2011-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04442737",
          "briefTitle": "A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV-1"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 103,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04318548",
          "briefTitle": "Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Meningococcal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 945,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06663189",
          "briefTitle": "Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsing-remitting Multiple Sclerosis (RRMS)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02384850",
          "briefTitle": "Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03"
          },
          "completionDateStruct": {
            "date": "2017-03-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Neoplasm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06100744",
          "briefTitle": "A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Psoriatic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06542887",
          "briefTitle": "Black Seed Oil in ADHD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "ADHD"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00505414",
          "briefTitle": "A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-06"
          },
          "completionDateStruct": {
            "date": "2009-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pain", "Neoplasm", "Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 136,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04409691",
          "briefTitle": "SCMC Trial on KHE With KMP (V.2020)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06168851",
          "briefTitle": "Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Immune Thrombocytopenia", "Treatment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01247922",
          "briefTitle": "Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-05-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-09-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ependymoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02345161",
          "briefTitle": "A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-23"
          },
          "completionDateStruct": {
            "date": "2016-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1811,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03693573",
          "briefTitle": "A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03551626",
          "briefTitle": "Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 552,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05518149",
          "briefTitle": "A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Depressive Disorder, Major"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 840,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07025590",
          "briefTitle": "Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cardiovascular Diseases (CVD)", "Depression Anxiety Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 106,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06902974",
          "briefTitle": "Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Post Traumatic Stress Disorder", "PTSD"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04650854",
          "briefTitle": "A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Generalized Myasthenia Gravis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 165,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01998841",
          "briefTitle": "A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alzheimer's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 252,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01214629",
          "briefTitle": "A Study for Participants With Advanced Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-07"
          },
          "completionDateStruct": {
            "date": "2012-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cancer", "Metastatic Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06942416",
          "briefTitle": "Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cervical Cancer", "Neoplasm Recurrence, Local", "Oligometastatic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03677830",
          "briefTitle": "Postoperative Pain Control & Relief in Neonates"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pain, Postoperative", "Premature Infant", "Opioid Use"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "1 Month"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03852498",
          "briefTitle": "A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cerebral Adrenoleukodystrophy (CALD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05834907",
          "briefTitle": "Hands and Hearts Together"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Parent-Child Relations", "Development, Infant", "Parenting", "Development, Child"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 249,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "8 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04000711",
          "briefTitle": "Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chemotherapy-Induced Febrile Neutropenia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 117,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06552234",
          "briefTitle": "Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC Stage IV", "NSCLC, Stage III"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02251977",
          "briefTitle": "Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09"
          },
          "completionDateStruct": {
            "date": "2017-09-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Colorectal Cancer", "Chemotherapy-induced Neutropenia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 196,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06568549",
          "briefTitle": "Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Transplantation", "Mycophenolate Mofetil"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 350,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00667862",
          "briefTitle": "Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-11-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05726266",
          "briefTitle": "Effect and Safety of Listening to Music for Chronic Pain Relief"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05232929",
          "briefTitle": "Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Spinal Muscular Atrophy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 402,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01774786",
          "briefTitle": "A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gastric Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 780,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03722966",
          "briefTitle": "Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking Cessation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02490475",
          "briefTitle": "A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-02"
          },
          "completionDateStruct": {
            "date": "2006-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02406222",
          "briefTitle": "Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06904079",
          "briefTitle": "Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Severe Mental Disorder", "Schizophrenia", "Schizoaffective Disorder", "Paranoid Psychosis", "Bipolar Affective Disorder", "Mental Disorders Due to Epilepsy", "Mental Retardation Accompanied by Mental Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00428389",
          "briefTitle": "Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-01"
          },
          "completionDateStruct": {
            "date": "2008-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alzheimer's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 262,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06773169",
          "briefTitle": "IAMABLE: Implementation and Evaluation of an App for Evidence-Based Self-Management Rehabilitation Strategies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Neurological Conditions", "Musculoskeletal Diseases or Conditions", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "44 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05476939",
          "briefTitle": "Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diffuse Intrinsic Pontine Glioma", "Diffuse Midline Glioma, H3 K27M-Mutant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 409,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05143931",
          "briefTitle": "Avoid and Resist Strategies for Weight Management"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-02-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Obesity", "Overweight"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 503,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "14 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01314872",
          "briefTitle": "A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-10-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Urinary Bladder, Overactive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1395,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06565689",
          "briefTitle": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05100862",
          "briefTitle": "A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed/Refractory Follicular Lymphoma", "Marginal Zone Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 780,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01149343",
          "briefTitle": "Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04639986",
          "briefTitle": "Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 331,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02222727",
          "briefTitle": "Effects of Donepezil on Regional Cerebral Blood Flow Following Aneurysmal Subarachnoid Haemorrhage"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01"
          },
          "completionDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Aneurysmal Subarachnoid Hemorrhage", "Delayed Neurological Deficit", "Delayed Cerebral Ischemia", "Vasospasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04427605",
          "briefTitle": "Efficacy and Safety of Continuous Infusion of Ketamine in Pediatric Intensive Care Unit (KISS Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Analgesia", "Ketamine Toxicity", "Bronchospasm", "Sedation Complication"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02738879",
          "briefTitle": "Randomized Sitagliptin Withdrawal Study (MK-0431-845)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 746,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03751124",
          "briefTitle": "Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Uterine Leiomyoma", "Uterine Fibroids"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 229,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "51 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05091346",
          "briefTitle": "A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Carcinoma, Hepatocellular", "Colorectal Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 89,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04154189",
          "briefTitle": "A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteosarcoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00812279",
          "briefTitle": "Investigate the Exposure to Selected Smoke Constituents in Smokers Switching to Distillation Based Smoking Article"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-11"
          },
          "completionDateStruct": {
            "date": "2009-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "23 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01231620",
          "briefTitle": "A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-03-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza, Human"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 626,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07275762",
          "briefTitle": "Y-4 to Treat the Postherpetic Neuralgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Postherpetic Neuralgia", "Y-4", "Pregabalin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03720041",
          "briefTitle": "Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 740,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03267940",
          "briefTitle": "Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cholangiocarcinoma Non-resectable", "Cholangiocarcinoma, Intrahepatic", "Cholangiocarcinoma, Extrahepatic", "Gallbladder Adenocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06095115",
          "briefTitle": "A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Plaque Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 684,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00781911",
          "briefTitle": "A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02"
          },
          "completionDateStruct": {
            "date": "2016-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma", "Neuroendocrine Tumors"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02509273",
          "briefTitle": "Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sedation in Intensive Care"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01232283",
          "briefTitle": "Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Plaque Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 413,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04205838",
          "briefTitle": "Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diffuse Large B-Cell Lymphoma, Not Otherwise Specified", "High Grade B-Cell Lymphoma", "Progressive Disease", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent High Grade B-Cell Lymphoma", "Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma", "Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma", "Refractory Diffuse Large B-Cell Lymphoma", "Refractory High Grade B-Cell Lymphoma", "Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma", "Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07293026",
          "briefTitle": "Abdominal Acupuncture for Gastrointestinal Function Recovery After Gynecologic Laparoscopic Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Postoperative Complications", "Postoperative Gastrointestinal Dysfunction (POGD)", "Postoperative Ileus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06327932",
          "briefTitle": "HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Muscle-Invasive Bladder Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 320,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04514627",
          "briefTitle": "Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05979480",
          "briefTitle": "The Effects of Growth Hormone Treatment Discontinuation in Adults on Metabolic Profile, Body Composition and Quality Of Life (GAMBOL Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Adult Growth Hormone Deficiency"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "25 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07236606",
          "briefTitle": "RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-05-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["MPS II", "Hunter Syndrome (MPS II)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "4 Months",
          "maximumAge": "5 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03989310",
          "briefTitle": "An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pancreatic Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01284335",
          "briefTitle": "A Safety Study in Participants With Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07"
          },
          "completionDateStruct": {
            "date": "2016-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 234,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06487533",
          "briefTitle": "Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Opioid Withdrawal", "Opioid Use Disorder"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03503318",
          "briefTitle": "Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Schizophrenia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 544,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "65 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT04707391",
          "briefTitle": "Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Meningitis, Meningococcal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1250,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03130790",
          "briefTitle": "Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gastric Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05938179",
          "briefTitle": "A Study of HS-10353 in Adult Participants With Major Depressive Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Major Depressive Disorder (MDD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 144,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00642460",
          "briefTitle": "A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05"
          },
          "completionDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Idiopathic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02178592",
          "briefTitle": "Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Infection, Human Immunodeficiency Virus", "HIV Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01949532",
          "briefTitle": "Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01"
          },
          "completionDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed Multiple Myeloma", "End-stage Renal Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07108387",
          "briefTitle": "Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Giant Cell Arteritis (GCA)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06162715",
          "briefTitle": "GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Severe Obesity", "Obesity", "BMI Greater Than 30"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04649515",
          "briefTitle": "Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronavirus Disease-2019 (COVID-19)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03390504",
          "briefTitle": "A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Urothelial Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 629,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02229227",
          "briefTitle": "Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 814,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05126888",
          "briefTitle": "SCI-110 in the Treatment of Tourette Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Tourette Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 164,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00908037",
          "briefTitle": "Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09-30"
          },
          "completionDateStruct": {
            "date": "2014-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Purpura, Thrombocytopaenic, Idiopathic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06280872",
          "briefTitle": "Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Premature Birth", "Respiratory Distress Syndrome in Premature Infant", "Sepsis", "Intraventricular Hemorrhage of Prematurity", "Bronchodysplasia", "Jaundice"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "32 Weeks",
          "maximumAge": "36 Weeks"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00184002",
          "briefTitle": "Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-01-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-05-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Hodgkin's Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03971422",
          "briefTitle": "A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Generalized Myasthenia Gravis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02823977",
          "briefTitle": "Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Alcohol Withdrawal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05656170",
          "briefTitle": "Stellate Ganglion to Prevent Atrial Fibrillation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atrial Fibrillation New Onset"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01431170",
          "briefTitle": "Safety and Efficacy Study of Besivance for Treatment of Congenital Nasolacrimal Duct Obstruction in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09"
          },
          "completionDateStruct": {
            "date": "2014-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Congenital Nasolacrimal Duct Obstruction"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "12 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01029262",
          "briefTitle": "A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-01-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 239,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04452877",
          "briefTitle": "A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02908672",
          "briefTitle": "A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 514,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05171777",
          "briefTitle": "A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 179,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00093145",
          "briefTitle": "Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02395172",
          "briefTitle": "Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 792,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03853798",
          "briefTitle": "Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pyruvate Kinase Deficiency"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02888444",
          "briefTitle": "Smoking Relapse Prevention Among COPD Ex-smokers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Obstructive Pulmonary Disease", "Smoking Cessation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01250301",
          "briefTitle": "De-nicotinised Cigarettes Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-07"
          },
          "completionDateStruct": {
            "date": "2012-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Smoking Cessation", "Tobacco Dependence"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05973773",
          "briefTitle": "REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-27",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 272,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05319080",
          "briefTitle": "Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Schizophrenia and Related Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "22 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01539824",
          "briefTitle": "A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-03-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04517864",
          "briefTitle": "PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alopecia Areata"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05011916",
          "briefTitle": "The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Corneal Neovascularization"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05154487",
          "briefTitle": "A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Endometroid Endometrial Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01479621",
          "briefTitle": "A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01"
          },
          "completionDateStruct": {
            "date": "2013-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 909,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02361346",
          "briefTitle": "Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-Hodgkin's B-cell Lymphoma", "Leukemia, Lymphocytic, Chronic, B-Cell", "Small Lymphocytic Leukemia", "Diffuse Large B Cell Lymphoma", "Blood Cancer", "Hematological Malignancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06588387",
          "briefTitle": "A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Secondary Progressive Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 210,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02025985",
          "briefTitle": "Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Carcinoma", "Endometrial Carcinoma", "Cervical Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01471782",
          "briefTitle": "Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01"
          },
          "completionDateStruct": {
            "date": "2016-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoblastic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01184417",
          "briefTitle": "Phenobarbital for Acute Alcohol Withdrawal"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-01"
          },
          "completionDateStruct": {
            "date": "2010-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alcohol Withdrawal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01056289",
          "briefTitle": "Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-03"
          },
          "completionDateStruct": {
            "date": "2011-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Major Depressive Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 480,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02429791",
          "briefTitle": "Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 510,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01630733",
          "briefTitle": "A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-09"
          },
          "completionDateStruct": {
            "date": "2017-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 700,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00022698",
          "briefTitle": "Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-05"
          },
          "completionDateStruct": {
            "date": "2004-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 67,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06071884",
          "briefTitle": "Bridge Device for Surgical Pain for Rotator Cuff Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pain", "Rotator Cuff Injuries"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06340958",
          "briefTitle": "A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Adjunctive Treatment of Major Depressive Disorder (MDD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05614115",
          "briefTitle": "Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["End-stage Kidney Disease", "Kidney Disease, Chronic", "Dialysis", "Diabetic", "Non-diabetic", "Kidney Dysfunction", "Kidney Failure", "Hemodialysis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02681510",
          "briefTitle": "UW-CTRI Triple Medication Smoking Cessation Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-06-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06776510",
          "briefTitle": "A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Immune Thrombocytopenia", "Treatment"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05729243",
          "briefTitle": "Cytisine for Smoking Cessation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Tobacco Use Disorder", "Alcohol Use Disorder", "Smoking Cessation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01955473",
          "briefTitle": "Japanese Phase 1 Trial of Sym004 in Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06285370",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Szary Syndrome Previously Treated With Systemic Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-13",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cutaneous T-Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03475953",
          "briefTitle": "A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Colorectal Cancer Not MSI-H or MMR-deficient", "GIST", "Oesophageal or Gastric Carcinoma", "Biliary Tract Cancer", "Hepatocellular Carcinoma", "Soft-tissue Sarcoma", "Thyroid Cancer", "Gastro-enteropancreatic Neuroendocrine Tumor", "Non-small Cell Lung Cancer", "Solid Tumor, Adult", "Urothelial Carcinoma", "HPV-Related Carcinoma", "Triple Negative Breast Cancer", "Renal Carcinoma", "Mesotheliomas Pleural"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 747,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03834142",
          "briefTitle": "NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Pain", "Arthropathy of Knee", "Arthropathy of Hip", "Pain, Postoperative", "Kidney Transplant Donor", "Bariatric Surgery Candidate"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02720822",
          "briefTitle": "Breathlessness Exertion and Morphine Sulphate"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Obstructive Pulmonary Disease", "Dyspnea"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 171,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07189988",
          "briefTitle": "Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Alcohol Use Disorder"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06742502",
          "briefTitle": "Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Mediastinal Diffuse Large B-cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02743546",
          "briefTitle": "Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Lymphocytic, Chronic, B-Cell", "Lymphoma, Large B-Cell, Diffuse", "Lymphoma, Follicular", "Lymphoma, Mantle-Cell"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05023824",
          "briefTitle": "Efficacy of -blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostatic Hyperplasia", "Prostate Hyperplasia", "Prostatic Hypertrophy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "50 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05316246",
          "briefTitle": "Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "NK/T Cell Lymphoma Nos"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01773395",
          "briefTitle": "GVAX vs. Placebo for MDS/AML After Allo HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic Syndrome", "Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01909466",
          "briefTitle": "Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07"
          },
          "completionDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Schizophrenia", "Mental Disorder", "Nervous System Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 141,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00764439",
          "briefTitle": "Pilot Study of a New Nicotine Replacement Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-10"
          },
          "completionDateStruct": {
            "date": "2008-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking Cessation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 258,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06440005",
          "briefTitle": "A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Advanced Cancer", "Locally Advanced Carcinoma", "Metastatic Solid Tumor", "Breast Cancer", "Prostate Cancer", "Colorectal Cancer", "Pancreatic Cancer", "Liver Cancer", "Angiosarcoma", "Solid Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01560637",
          "briefTitle": "An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Arterial Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 471,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06139172",
          "briefTitle": "Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Telomeric 22Q13 Monosomy Syndrome", "Tuberous Sclerosis", "Hamartoma Syndrome, Multiple", "Fragile X Syndrome", "Angelman Syndrome", "Rett Syndrome", "Chromosome 15Q, Partial Deletion", "Creatine Deficiency, X-linked"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 92,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05874713",
          "briefTitle": "Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza, Human", "Infections", "Respiratory Tract Infections", "Virus Diseases", "Infection Viral"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 480,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04610476",
          "briefTitle": "Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Psoriatic Arthritis", "Withdrawal", "Reduction"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 270,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03485768",
          "briefTitle": "PDCN for Treatment of Cervical Vertigo"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cervical Vertigo"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00281684",
          "briefTitle": "SB-705498 Dental Pain Study After Tooth Extraction"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-10-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Toothache"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 145,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03818035",
          "briefTitle": "A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 880,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00224406",
          "briefTitle": "Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-09-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ischemia-Reperfusion Injury", "Lung Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 114,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03178552",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Small Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00702338",
          "briefTitle": "Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-12-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pregnancy", "Neonates"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "39 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04308785",
          "briefTitle": "A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Small Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01214655",
          "briefTitle": "A Study for Patients With Acute Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06"
          },
          "completionDateStruct": {
            "date": "2011-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05818735",
          "briefTitle": "Effect of Electroacupuncture on Treating the First-episode Depression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Depression"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01545076",
          "briefTitle": "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03"
          },
          "completionDateStruct": {
            "date": "2016-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Inflammatory Demyelinating Polyneuropathy", "Polyradiculoneuropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 208,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04236791",
          "briefTitle": "The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking Cessation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1246,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04980391",
          "briefTitle": "A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Respiratory Syncytial Virus Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 384,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "15 Years",
          "maximumAge": "49 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06422858",
          "briefTitle": "Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05249829",
          "briefTitle": "A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS-CoV-2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3548,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00792571",
          "briefTitle": "An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Arterial Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02027701",
          "briefTitle": "Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06540144",
          "briefTitle": "An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Generalized Myasthenia Gravis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01987232",
          "briefTitle": "Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-05"
          },
          "completionDateStruct": {
            "date": "2017-05-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Extensive-Stage Small-Cell Lung Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01194219",
          "briefTitle": "Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-11-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Plaque Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 844,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03356145",
          "briefTitle": "12 Versus 20 mL PCB for D&E Cervical Prep"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 96,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01199822",
          "briefTitle": "Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignancy", "Metastasis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00712933",
          "briefTitle": "A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 738,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01367600",
          "briefTitle": "Open-Label Treatment Extension of Protocol MNTX 301"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-02"
          },
          "completionDateStruct": {
            "date": "2005-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Terminal Illness"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00088452",
          "briefTitle": "Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Childhood Absence Epilepsy", "Petit Mal Epilepsy", "Epilepsy", "Seizures"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 453,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "30 Months",
          "maximumAge": "13 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07042685",
          "briefTitle": "Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Colorectal Cancer (CRC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06500884",
          "briefTitle": "A Study to Evaluate Preventive Treatments for Talquetamab-related Oral Toxicity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapse Multiple Myeloma", "Refractory Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01765647",
          "briefTitle": "Oral AGY for Celiac Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05"
          },
          "completionDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Celiac Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02479087",
          "briefTitle": "Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01"
          },
          "completionDateStruct": {
            "date": "2020-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00326963",
          "briefTitle": "BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03"
          },
          "completionDateStruct": {
            "date": "2007-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 142,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06085287",
          "briefTitle": "Electromagnetic Therapy for Autism Spectrum Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Autism Spectrum Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01995201",
          "briefTitle": "A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 401,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02426034",
          "briefTitle": "A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Gastric or Gastroesophageal Junction Adenocarcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2004,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT01807871",
          "briefTitle": "Treatment of Smoking Lapses and Relapses"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03"
          },
          "completionDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking Cessation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 701,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04751500",
          "briefTitle": "The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Retained Products After Miscarriage"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 149,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02941809",
          "briefTitle": "Harnessing Placebo Effects in Methadone Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Opioid-use Disorder", "Opioid-Related Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 133,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00814099",
          "briefTitle": "Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-01"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiratory Insufficiency", "Respiratory Distress Syndrome, Newborn", "Lung Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2449,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Weeks",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04280497",
          "briefTitle": "Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sepsis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1800,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01536574",
          "briefTitle": "Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09-02"
          },
          "completionDateStruct": {
            "date": "2012-03-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Parkinson Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 295,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05609968",
          "briefTitle": "Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) 50% (MK-3475-D46)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-08-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 614,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05169190",
          "briefTitle": "Stellate Ganglion Block for PTSD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Post-traumatic Stress Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 410,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04003207",
          "briefTitle": "Growth Hormone Treatment in Children With Phelan McDermid Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Phelan McDermid Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00048893",
          "briefTitle": "Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-11"
          },
          "completionDateStruct": {
            "date": "2011-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Neoplasms", "Metastases, Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01754857",
          "briefTitle": "Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoid Leukemia", "Small Lymphocytic Lymphoma", "Lymphoma, Non-Hodgkin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04446182",
          "briefTitle": "Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Graft-versus-host-disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07247370",
          "briefTitle": "Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Alcohol Use Disorder (AUD)", "Major Depressive Disorder (MDD)", "Comorbidities and Coexisting Conditions"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01798485",
          "briefTitle": "A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-Small-Cell Lung Adenocarcinoma", "Non-small Cell Lung Cancer Stage IIIB", "Non-small Cell Lung Cancer Stage IV", "Non-small Cell Lung Cancer Metastatic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 696,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01021813",
          "briefTitle": "A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Insomnia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 781,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00475423",
          "briefTitle": "A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-05"
          },
          "completionDateStruct": {
            "date": "2011-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Thrombocytopenic Purpura"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 122,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06977828",
          "briefTitle": "A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC (Non-small Cell Lung Cancer)", "Neoadjuvant Immunotherapy", "Adjuvant Immunotherapy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05946304",
          "briefTitle": "Exercise Training in Women With Cardiac Devices"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cardiovascular Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00988221",
          "briefTitle": "A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-01-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Idiopathic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 188,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01205165",
          "briefTitle": "An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2006-04-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis B, Chronic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 104,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00915564",
          "briefTitle": "A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {
            "date": "2010-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01588184",
          "briefTitle": "An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 95,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05082285",
          "briefTitle": "A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Meningococcal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 724,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "55 Days",
          "maximumAge": "89 Days"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01713426",
          "briefTitle": "A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-09-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-diabetic Painful Peripheral Polyneuropathy", "Postherpetic Neuralgia (PHN)", "Peripheral Nerve Injury (PNI)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 568,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05327114",
          "briefTitle": "Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 201,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01780714",
          "briefTitle": "Exploratory THS 2.1 Biomarkers of Exposure Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06"
          },
          "completionDateStruct": {
            "date": "2012-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "23 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06892925",
          "briefTitle": "QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Biliary Tract Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 59,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04034316",
          "briefTitle": "Reduce Immunosuppression With Atmp in NS ChildrEn"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Nephrotic Syndrome in Children", "Steroid-Dependent Nephrotic Syndrome", "Idiopathic Nephrotic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02029001",
          "briefTitle": "Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Solid Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 900,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04603807",
          "briefTitle": "A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05367492",
          "briefTitle": "Varenicline for Nicotine Vaping Cessation in Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Vaping", "Nicotine Dependence"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 261,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04602494",
          "briefTitle": "Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Vaping", "Nicotine Dependence"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04997161",
          "briefTitle": "Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hyperkalaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02423603",
          "briefTitle": "PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07055607",
          "briefTitle": "A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Obesity"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00917384",
          "briefTitle": "Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Gastric Cancer", "Adenocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 355,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03113760",
          "briefTitle": "Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["NLRC4-MAS", "XIAP Deficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00333788",
          "briefTitle": "Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-10"
          },
          "completionDateStruct": {
            "date": "2010-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 233,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02494596",
          "briefTitle": "A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-01"
          },
          "completionDateStruct": {
            "date": "2005-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01791296",
          "briefTitle": "Does Nightly Dexmedetomidine Improve Sleep and Reduce Delirium in ICU Patients?"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Sleep Deprivation", "Delirium"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04181827",
          "briefTitle": "A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-04-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 419,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07264907",
          "briefTitle": "Tai Chi Improves Sleep Quality in Mild to Moderate Chronic Insomnia Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Insomnia"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03823989",
          "briefTitle": "Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Solid Tumor", "Metastatic Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00635089",
          "briefTitle": "Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eosinophilic Esophagitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 190,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02488330",
          "briefTitle": "An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06961565",
          "briefTitle": "PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["NF1 Mutation", "Neurofibroma Plexiform", "Neurofibroma, Plexiform", "Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)", "Neurofibromatosis Type 1 (NF1)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02401815",
          "briefTitle": "CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gastrointestinal Stromal Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01454362",
          "briefTitle": "Effect of the Electronic Cigarette on Withdrawal Symptoms"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01"
          },
          "completionDateStruct": {
            "date": "2013-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Mental and Behavioral Disorders", "Withdrawal State"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03139851",
          "briefTitle": "Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Breast Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06183437",
          "briefTitle": "The STOP-MED CTRCD Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Heart Failure", "Cardiotoxicity", "Cardiac Toxicity", "Antineoplastics Toxicity", "Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 335,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03977233",
          "briefTitle": "Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pancreatic Ductal Adenocarcinoma (PDAC)", "Cancer of Pancreas", "Pancreatic Cancer, Adult", "Pancreas Adenocarcinoma", "Pancreatic Neoplasms", "Pancreatic Cancer Non-resectable", "Pancreatic Cancer Resectable"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05493501",
          "briefTitle": "Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "NSCLC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04600414",
          "briefTitle": "Collaborating to Heal Addiction and Mental Health in Primary Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Opioid-use Disorder", "Mental Health Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 254,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03185481",
          "briefTitle": "Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Parkinson's Disease With Motor Fluctuations"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "87 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01023789",
          "briefTitle": "ABSORB EXTEND Clinical Investigation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-01"
          },
          "completionDateStruct": {
            "date": "2016-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myocardial Ischemia", "Coronary Artery Stenosis", "Coronary Disease", "Coronary Artery Disease", "Coronary Restenosis", "Cardiovascular Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 812,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02813785",
          "briefTitle": "A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Carcinoma, Non-Small-Cell Lung"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 565,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01227668",
          "briefTitle": "Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2012-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Irritability Associated With Autistic Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 215,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01118962",
          "briefTitle": "Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2012-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05786469",
          "briefTitle": "Patiromer Trial in CKD Stage IIIB to V"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hyperkalemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02563717",
          "briefTitle": "Comparison Of Respiratory Support After Delivery on Infants Born Before 28 Weeks Gestational Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiration; Insufficient or Poor, Newborn", "Infant, Premature, Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02547168",
          "briefTitle": "Determining the True Incidence of Atrial Fibrillation Before and After Lung Resection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lung Cancer", "Atrial Fibrillation", "Stroke"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01606137",
          "briefTitle": "A Study of the Long-term Safety of Sativex Use"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-02"
          },
          "completionDateStruct": {
            "date": "2004-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Sclerosis", "Spasticity", "Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 507,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04004234",
          "briefTitle": "A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Biliary Tract Cancer (BTC)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00705016",
          "briefTitle": "Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-10"
          },
          "completionDateStruct": {
            "date": "2013-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Squamous Cell Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 184,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01090414",
          "briefTitle": "An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Lymphocytic Leukemia", "Lymphoma, Non-Hodgkin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 202,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02866370",
          "briefTitle": "Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04"
          },
          "completionDateStruct": {
            "date": "2021-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Clear Cell Carcinoma", "Endometrial Clear Cell Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06588270",
          "briefTitle": "Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Schizophrenia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00914056",
          "briefTitle": "A Study of Controlled Lactulose Withdrawal"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-09"
          },
          "completionDateStruct": {
            "date": "2012-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatic Encephalopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05087056",
          "briefTitle": "Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-02-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Meningitis, Meningococcal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 302,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "11 Years",
          "maximumAge": "14 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03968237",
          "briefTitle": "Measures to Improve Outcomes After an Opioid Overdose"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Opioid Overdose"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00999245",
          "briefTitle": "THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-01"
          },
          "completionDateStruct": {
            "date": "2010-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06039072",
          "briefTitle": "Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cardiomyopathy, Dilated"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "20 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01332019",
          "briefTitle": "Long-Term Safety and Efficacy Study of Peginterferon Beta-1a"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-04"
          },
          "completionDateStruct": {
            "date": "2015-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsing Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1077,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02831764",
          "briefTitle": "An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment nave HIV Infected Participants (Gemini 2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Infection, Human Immunodeficiency Virus", "HIV Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 722,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05853263",
          "briefTitle": "Morphine IV vs Paracetamol IV in Neonates and Infants After Cardiac Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Analgesia", "Congenital Heart Disease", "Surgery"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 208,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Day",
          "maximumAge": "36 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01336621",
          "briefTitle": "Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-09-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02494921",
          "briefTitle": "LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05307679",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dup15q Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "14 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03414450",
          "briefTitle": "Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)", "Ph- Acute Lymphoblastic Leukemia (Ph-ALL)", "Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+)", "Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03525678",
          "briefTitle": "A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 221,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05024968",
          "briefTitle": "Sintilimab in Cancer of Unknown Primary"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer of Unknown Primary Site"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03416179",
          "briefTitle": "A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myeloid, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 730,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03126747",
          "briefTitle": "Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Endometriosis and Dysmenorrhea"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 715,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01192867",
          "briefTitle": "A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-05-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Schizophrenia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 629,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04768881",
          "briefTitle": "Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Locally Advanced Unresectable or Metastatic Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03630614",
          "briefTitle": "Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Smoking Cessation", "Smoking, Cigarette", "Electronic Cigarette"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 650,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01544595",
          "briefTitle": "Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-06-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Moderate to Severe Plaque-type Psoriasis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1147,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03144687",
          "briefTitle": "A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "MPN (Myeloproliferative Neoplasms)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02417467",
          "briefTitle": "Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation (E3) Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11"
          },
          "completionDateStruct": {
            "date": "2020-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking Cessation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 376,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00782067",
          "briefTitle": "Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04951609",
          "briefTitle": "A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Depressive Disorder, Major"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00268203",
          "briefTitle": "Expanded Access Study Of BEXXAR For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-09"
          },
          "completionDateStruct": {
            "date": "2013-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 765,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01307397",
          "briefTitle": "A Study of Vemurafenib in Participants With Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-02-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3219,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07262788",
          "briefTitle": "A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04331288",
          "briefTitle": "Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Potential Treatment for Alcohol Dependence-Alcohol Interaction"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02201459",
          "briefTitle": "Nilotinib  Peg-IFN for First Line Chronic Phase CML Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08"
          },
          "completionDateStruct": {
            "date": "2022-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07125261",
          "briefTitle": "BHV-7000 Responsive Neurostimulation System (RNS) Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Epilepsy", "Seizures"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02720458",
          "briefTitle": "Self Help Program for Hypnotics Withdrawal in Insomniac Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Insomnia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03682848",
          "briefTitle": "Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05599191",
          "briefTitle": "A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cough", "Refractory Chronic Cough"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 825,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      }
    ]
  }
}
